The hedge fund’s shares of CHS are valued at $496,037. CHS makes up about 0.22 percent of Palouse Capital’s portfolio, according to Founders Daily.
Other hedge funds, including Dupont Capital Management, also reduced their stakes in CHS in the most recent quarter.
More articles on healthcare finance:
Fitch: Clinton’s healthcare plan could benefit hospitals in the near term, but long-term effects uncertain
CMS makes offer to clear Medicare appeals backlog: 6 things to know
UPMC operating margin shrinks in Q1
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
